Cargando…
Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia
The neurobiological effects of clozapine are under characterised. We examined the effects clozapine treatment on subcortical volume and cortical thickness and investigated whether macrostructural changes were linked to alterations in glutamate or N-acetylaspartate (NAA). Data were acquired in 24 pat...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891256/ https://www.ncbi.nlm.nih.gov/pubmed/35236831 http://dx.doi.org/10.1038/s41537-022-00230-2 |
_version_ | 1784661831106691072 |
---|---|
author | Krajner, Fanni Hadaya, Laila McQueen, Grant Sendt, Kyra-Verena Gillespie, Amy Avila, Alessia Lally, John Hedges, Emily P. Diederen, Kelly Howes, Oliver D. Barker, Gareth J. Lythgoe, David J. Kempton, Matthew J. McGuire, Philip MacCabe, James H. Egerton, Alice |
author_facet | Krajner, Fanni Hadaya, Laila McQueen, Grant Sendt, Kyra-Verena Gillespie, Amy Avila, Alessia Lally, John Hedges, Emily P. Diederen, Kelly Howes, Oliver D. Barker, Gareth J. Lythgoe, David J. Kempton, Matthew J. McGuire, Philip MacCabe, James H. Egerton, Alice |
author_sort | Krajner, Fanni |
collection | PubMed |
description | The neurobiological effects of clozapine are under characterised. We examined the effects clozapine treatment on subcortical volume and cortical thickness and investigated whether macrostructural changes were linked to alterations in glutamate or N-acetylaspartate (NAA). Data were acquired in 24 patients with treatment-resistant schizophrenia before and 12 weeks after switching to clozapine. During clozapine treatment we observed reductions in caudate and putamen volume, lateral ventricle enlargement (P < 0.001), and reductions in thickness of the left inferior temporal cortex, left caudal middle frontal cortex, and the right temporal pole. Reductions in right caudate volume were associated with local reductions in NAA (P = 0.002). None of the morphometric changes were associated with changes in glutamate levels. These results indicate that clozapine treatment is associated with subcortical volume loss and cortical thinning and that at least some of these effects are linked to changes in neuronal or metabolic integrity. |
format | Online Article Text |
id | pubmed-8891256 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-88912562022-03-17 Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia Krajner, Fanni Hadaya, Laila McQueen, Grant Sendt, Kyra-Verena Gillespie, Amy Avila, Alessia Lally, John Hedges, Emily P. Diederen, Kelly Howes, Oliver D. Barker, Gareth J. Lythgoe, David J. Kempton, Matthew J. McGuire, Philip MacCabe, James H. Egerton, Alice Schizophrenia (Heidelb) Article The neurobiological effects of clozapine are under characterised. We examined the effects clozapine treatment on subcortical volume and cortical thickness and investigated whether macrostructural changes were linked to alterations in glutamate or N-acetylaspartate (NAA). Data were acquired in 24 patients with treatment-resistant schizophrenia before and 12 weeks after switching to clozapine. During clozapine treatment we observed reductions in caudate and putamen volume, lateral ventricle enlargement (P < 0.001), and reductions in thickness of the left inferior temporal cortex, left caudal middle frontal cortex, and the right temporal pole. Reductions in right caudate volume were associated with local reductions in NAA (P = 0.002). None of the morphometric changes were associated with changes in glutamate levels. These results indicate that clozapine treatment is associated with subcortical volume loss and cortical thinning and that at least some of these effects are linked to changes in neuronal or metabolic integrity. Nature Publishing Group UK 2022-03-02 /pmc/articles/PMC8891256/ /pubmed/35236831 http://dx.doi.org/10.1038/s41537-022-00230-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Krajner, Fanni Hadaya, Laila McQueen, Grant Sendt, Kyra-Verena Gillespie, Amy Avila, Alessia Lally, John Hedges, Emily P. Diederen, Kelly Howes, Oliver D. Barker, Gareth J. Lythgoe, David J. Kempton, Matthew J. McGuire, Philip MacCabe, James H. Egerton, Alice Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia |
title | Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia |
title_full | Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia |
title_fullStr | Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia |
title_full_unstemmed | Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia |
title_short | Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia |
title_sort | subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891256/ https://www.ncbi.nlm.nih.gov/pubmed/35236831 http://dx.doi.org/10.1038/s41537-022-00230-2 |
work_keys_str_mv | AT krajnerfanni subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia AT hadayalaila subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia AT mcqueengrant subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia AT sendtkyraverena subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia AT gillespieamy subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia AT avilaalessia subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia AT lallyjohn subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia AT hedgesemilyp subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia AT diederenkelly subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia AT howesoliverd subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia AT barkergarethj subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia AT lythgoedavidj subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia AT kemptonmatthewj subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia AT mcguirephilip subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia AT maccabejamesh subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia AT egertonalice subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia |